BIOTRICITY INC.
For the period ended Dec 31, 2024. Filed Feb 19, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2024 · Filed Feb 19, 2025
BTCY$0.06+7.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. – Condensed Consolidated Financial Statements
| Condensed Consolidated Balance Sheets at December 31, 2024 (unaudited) and March 31, 2024 (audited) | 4 |
|---|---|
| Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended December 31, 2024 and 2023 (unaudited) | 5 |
| Condensed Consolidated Statements of Mezzanine Equity and Stockholders’ Deficiency for the three and nine months ended December 31, 2024 and 2023 (unaudited) | 6 |
| Condensed Consolidated Statements of Cash Flows for the nine months ended December 31, 2024 and 2023 (unaudited) | 10 |
| Notes to the Condensed Consolidated Financial Statements | 11 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.